SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Stroke risk in older British men: Comparing performance of stroke-specific and composite-CVD risk prediction tools.

Ahmed, A; Ambler, G; Pinto Pereira, SM; Lennon, L; Papacosta, O; Whincup, P; Wannamethee, G (2022) Stroke risk in older British men: Comparing performance of stroke-specific and composite-CVD risk prediction tools. Prev Med Rep, 31. p. 102098. ISSN 2211-3355 https://doi.org/10.1016/j.pmedr.2022.102098
SGUL Authors: Whincup, Peter Hynes

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (539kB) | Preview
[img] Microsoft Word (.docx) (Supplementary data 1) Published Version
Available under License Creative Commons Attribution.

Download (219kB)

Abstract

Stroke risk is currently estimated as part of the composite risk of cardiovascular disease (CVD). We investigated if composite-CVD risk prediction tools QRISK3 and Pooled Cohort Equations-PCE, derived from middle-aged adults, are as good as stroke-specific Framingham Stroke Risk Profile-FSRP and QStroke for capturing the true risk of stroke in older adults. External validation for 10y stroke outcomes was performed in men (60-79y) of the British Regional Heart Study. Discrimination and calibration were assessed in separate validation samples (FSRP n = 3762, QStroke n = 3376, QRISK3 n = 2669 and PCE n = 3047) with/without adjustment for competing risks. Sensitivity/specificity were examined using observed and clinically recommended thresholds. Performance of FSRP, QStroke and QRISK3 was further compared head-to-head in 2441 men free of a range of CVD, including across age-groups. Observed 10y risk (/1000PY) ranged from 6.8 (hard strokes) to 11 (strokes/transient ischemic attacks). All tools discriminated weakly, C-indices 0.63-0.66. FSRP and QStroke overestimated risk at higher predicted probabilities. QRISK3 and PCE showed reasonable calibration overall with minor mis-estimations across the risk range. Performance worsened on adjusting for competing non-stroke deaths. However, in men without CVD, QRISK3 displayed relatively better calibration for stroke events, even after adjustment for competing deaths, including in oldest men. All tools displayed similar sensitivity (63-73 %) and specificity (52-54 %) using observed risks as cut-offs. When QRISK3 and PCE were evaluated using thresholds for CVD prevention, sensitivity for stroke events was 99 %, with false positive rate 97 % suggesting existing intervention thresholds may need to be re-examined to reflect age-related stroke burden.

Item Type: Article
Additional Information: © 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: AF, atrial fibrillation, BRHS, British Regional Heart Study, CHD, coronary heart disease, CIF, cumulative incidence function, CPI, centred prognostic index, CVD, cardiovascular disease, Calibration, Cardiovascular disease, Discrimination, FSRP, Framingham stroke risk profile, HF, heart failure, KM, Kaplan-Meier, MI, myocardial infarction, NICE, National Institute For Health And Care Excellence, Older adults, PCE, pooled cohort equations, PI, prognostic index, Risk prediction, SCORE, systematic coronary risk evaluation, Sn/Sp, percent sensitivity/percent specificity, Stroke, TIA, transient ischemic attack, Calibration, Cardiovascular disease, Discrimination, Older adults, Risk prediction, Stroke, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Prev Med Rep
ISSN: 2211-3355
Language: eng
Dates:
DateEvent
29 December 2022Published
24 December 2022Published Online
22 December 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/N013867/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/P020372/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
RG/19/4/34452British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PubMed ID: 36820364
Web of Science ID: WOS:000978334300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115517
Publisher's version: https://doi.org/10.1016/j.pmedr.2022.102098

Actions (login required)

Edit Item Edit Item